Evaluation of IL-6, vitamin D level in chronic periodontitis patients after non-surgical periodontal therapy
Abstract
Background and aims: Vitamin D is hypothesized to prevent periodontal disease progression through immune modulation and regulation of systemic calcium. A multifunctional cytokine, interleukin (IL)-6, mediates tissue injury, infection, and bone resorption in periodontitis. The goal of Phase I therapy is to halt the disease progression. Hence, this study aims at correlating the serum level of Vitamin D and IL-6 in patients with chronic periodontitis before and following periodontal non-surgical therapy.
Material and method: A total of 60 patients were divided into two groups of 30 each, comprising healthy and chronic periodontitis patients, respectively. Clinical parameters were recorded at baseline and post-treatment. Serum samples were analyzed to estimate Vitamin D levels and IL-6 levels
Results: At baseline, the mean serum IL-6 levels were significantly higher in group B (49.13 ± 5.65) and, the serum vitamin D level indicated an insufficiency (20.62 ± 5.76). However, following non-surgical periodontal therapy, the vitamin D level improved (31.76± 8.12) and IL-6 level decreased markedly (40.16± 7.88). In addition, there was an improvement in the clinical parameters.
Conclusions: It can be concluded that there is an association between chronic periodontitis, Vitamin D and IL-6 indicating their potential role as risk indicators for periodontal disease.